ACE2 and lung adenocarcinoma: Patients with lung adenocarcinomas (LUAD) also display variable expressions of ACE2 across the different cell types within the tumors [14–16].Similar to COVID-19 infections, altered ACE2 expression in LUAD is associated with the inflammatory signalling pathway via the actions of RAAS [17, 18].